R N J de Nijs

Summary

Country: The Netherlands

Publications

  1. ncbi Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies
    R N J de Nijs
    Department of Rheumatology and Clinical Immunology, F02 127, University Medical Center Utrecht, PO Box 85500, 3508 GA, The Netherlands
    Osteoporos Int 15:589-602. 2004
  2. ncbi Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis
    Ron N J de Nijs
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
    N Engl J Med 355:675-84. 2006
  3. ncbi Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options
    R N J de Nijs
    Center for Rheumatology, Maxima Medical Center, Eindhoven, The Netherlands
    Minerva Med 99:23-43. 2008
  4. pmc Prevention of glucocorticoid osteoporosis: a consensus document of the Dutch Society for Rheumatology
    P P Geusens
    Ann Rheum Dis 63:324-5. 2004
  5. ncbi [Eosinophilic fasciitis; the importance of early detection for optimal outcomes]
    J W E Hokken
    afd Interne Geneeskunde, Maxima Medisch Centrum, Veldhoven
    Ned Tijdschr Geneeskd 152:657-62. 2008

Collaborators

Detail Information

Publications5

  1. ncbi Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies
    R N J de Nijs
    Department of Rheumatology and Clinical Immunology, F02 127, University Medical Center Utrecht, PO Box 85500, 3508 GA, The Netherlands
    Osteoporos Int 15:589-602. 2004
    ..Bisphosphonates, however, are more effective in preserving bone and decreasing the risk of vertebral fractures than active vitamin D3 analogues...
  2. ncbi Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis
    Ron N J de Nijs
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
    N Engl J Med 355:675-84. 2006
    ..Treatment with glucocorticoids is associated with bone loss starting soon after therapy is initiated and an increased risk of fracture...
  3. ncbi Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options
    R N J de Nijs
    Center for Rheumatology, Maxima Medical Center, Eindhoven, The Netherlands
    Minerva Med 99:23-43. 2008
    ..Further training of health care workers in pathophysiology, general measurements and pharmacological intervention for prevention and treatment of glucocorticoid-induced osteoporosis, is needed...
  4. pmc Prevention of glucocorticoid osteoporosis: a consensus document of the Dutch Society for Rheumatology
    P P Geusens
    Ann Rheum Dis 63:324-5. 2004
  5. ncbi [Eosinophilic fasciitis; the importance of early detection for optimal outcomes]
    J W E Hokken
    afd Interne Geneeskunde, Maxima Medisch Centrum, Veldhoven
    Ned Tijdschr Geneeskd 152:657-62. 2008
    ..Initiation of systemic glucocorticoid therapy at an early stage results in a good response and remission of symptoms. This is illustrated in 3 cases of EF to demonstrate the importance of early detection in this disease...